These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1299708)

  • 1. Does isoniazid increase the hepatotoxicity of the combination prothionamide-dapsone? Isoprodian Study Group.
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):536-41. PubMed ID: 1299708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Malta experience. Isoprodian-rifampicin combination treatment for leprosy.
    Depasquale G
    Lepr Rev; 1986; 57 Suppl 3():29-37. PubMed ID: 3573957
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.
    Chum HJ
    Lepr Rev; 1986; 57 Suppl 3():63-6. PubMed ID: 3573963
    [No Abstract]   [Full Text] [Related]  

  • 4. Side-effects of Isoprodian compared with WHO-MDT in rural Nepal.
    van Brakel WH; Drever W
    Lepr Rev; 1993 Sep; 64(3):276-80. PubMed ID: 8231610
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term prothionamide compliance: a study carried out in India using a combined formulation containing prothionamide, dapsone and isoniazid.
    Ellard GA; Kiran KU; Stanley JN
    Lepr Rev; 1988 Jun; 59(2):163-75. PubMed ID: 3246926
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatotoxicity of the daily combination of 5 mg/kg prothionamide + 10 mg/kg rifampin.
    Cartel JL; Naudillon Y; Artus JC; Grosset JH
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):15-8. PubMed ID: 3998559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First assessment of the Malta Leprosy Eradication Project.
    Leiker DL
    Lepr Rev; 1986; 57 Suppl 3():42-6. PubMed ID: 3573959
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of DDS with two combined chemotherapy regimens for multibacillary leprosy. Results after 3 years of treatment. A prospective randomized multicentre study.
    Dietrich M; Wabitsch R
    Lepr Rev; 1986; 57 Suppl 3():60-2. PubMed ID: 3573962
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis in leprosy patients treated by a daily combination of dapsone, rifampin, and a thioamide.
    Cartel JL; Millan J; Guelpa-Lauras CC; Grosset JH
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):461-5. PubMed ID: 6686970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.
    Jacobson RR; Gatt P
    Lepr Rev; 2008 Dec; 79(4):410-5. PubMed ID: 19274987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New drugs in the treatment of leprosy].
    De Las Aguas JT
    Med Cutan Ibero Lat Am; 1976; 4(5):365-70. PubMed ID: 1035391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acceptability, compliance and tolerance of daily polychemotherapy by leprosy patients in Guadeloupe].
    Cartel JL; Gallais JJ; Grosset JH
    Acta Leprol; 1985; 3(4):339-55. PubMed ID: 3913270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
    Fajardo TT; Guinto RS; Cellona RV; Abalos RM; Dela Cruz EC; Gelber RH
    Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of leprosy with rifampicin and isoprodian in 38 patients at St. Thomas Hospital, Chetput, Sout India.
    Aschhoff M
    Lepr Rev; 1975 Jun; 46(2 Suppl):173-8. PubMed ID: 1165697
    [No Abstract]   [Full Text] [Related]  

  • 16. Preliminary experience with rifampicin and isoprodian in combination in leprosy treatment.
    Krenzien HN
    Lepr Rev; 1975 Jun; 46(2 Suppl):189-98. PubMed ID: 1100960
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampicin and isoprodian in combination in the treatment of leprosy.
    Depasquale G
    Lepr Rev; 1975 Jun; 46(2 Suppl):179-80. PubMed ID: 1100958
    [No Abstract]   [Full Text] [Related]  

  • 18. Dapsone hypersensitivity syndrome in a lepromatous leprosy patient--A Case Report.
    Gavilanes MC; Palacio AL; Chellini PR; Nery JA; Rego JG
    Lepr Rev; 2015 Jun; 86(2):186-90. PubMed ID: 26502691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of rifampicin and isoprodian in the treatment of Mycobacterium leprae infections in mice.
    Matsuo Y; Utsunomiya S; Kajihara N; Kim SK
    Nihon Rai Gakkai Zasshi; 1978; 47(1):43-7. PubMed ID: 701209
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of a prothionamide-containing oral antituberculosis regimen.
    Langton ME; Cowie RL
    S Afr Med J; 1985 Dec; 68(12):881. PubMed ID: 4071346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.